Clinical Trials List
Protocol NumberSTGLA031210
2004-01-01 - 2006-12-31
Phase III
Terminated2
-
Trial Applicant
-
Sponsor
-
Trial scale
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 裴馰 Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
50 participants
-
Global
0 participants
